Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5899 clinical trials
Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

The investigators are doing this study to find out whether lowering the dose of postoperative radiation therapy and targeting a smaller area of tissue for treatment is as effective as the standard dose and volume of radiation therapy to control soft tissue sarcoma after surgery. They also want to find …

primary tumor
serum pregnancy test
sarcoma of the extremity
sarcoma
soft tissue sarcoma
  • 0 views
  • 19 Feb, 2024
  • 7 locations
Black Raspberry Nectar for the Prevention of Lung Cancer BE WELL Study

This trial studies how well black raspberry nectar works in changing the gut microbiome and in reducing inflammatory processes that may lead to lung cancer. Studying the effects of black raspberry beverage on inflammation may help doctors find strategies to reduce the risk of developing lung cancer.

vitamins
cancer
carcinoma
lung carcinoma
lung cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
MCB Vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT

Gastrointestinal stromal tumors (GISTs) are the most common submucosal tumors (SMTs) of the stomach. The 2022 European Society of Oncology ESMO Diagnosis and Treatment Guidelines recommend that GISTs undergo biopsy with a clear pathological diagnosis and should be removed unless there are significant complications.

  • 0 views
  • 07 May, 2025
  • 1 location
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

This study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene fusion.

blood transfusion
direct bilirubin
solid tumor
platelet count
metastatic solid tumor
  • 0 views
  • 19 Feb, 2024
  • 1 location
Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors

This is an open, two-stage, phase I study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of AB011 injection in patients with CLDN18.2-positive advanced solid tumors.

solid tumour
treatment regimen
solid neoplasm
  • 0 views
  • 19 Feb, 2024
  • 1 location
Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer

This phase I trial studies how well cemiplimab before and after surgery works in treating patients with high risk cutaneous squamous cell cancer. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow …

extranodal extension
hormone replacement therapy
primary lesion
heparin
monoclonal antibodies
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer

This study will evaluate the safety, tolerability, and pharmacokinetics of BLYG8824A and will make a preliminary assessment of the anti-tumor activity of BLYG8824A in patients with locally advanced or metastatic colorectal cancer.

PCR test
monoclonal antibodies
oxaliplatin
measurable disease
antibody therapy
  • 0 views
  • 19 Feb, 2024
  • 6 locations
A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors

This research study is studying a new drug, NC410, as a possible treatment for advanced or metastatic solid tumors.

serum pregnancy test
systemic therapy
measurable disease
bilateral oophorectomy
solid tumour
  • 0 views
  • 19 Feb, 2024
  • 1 location
Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901

To evaluate the efficacy and safety of Pembrolizumab + Pemetrexed in elderly patients with non-squamous non-small cell lung cancer with Programmed cell death (PD) -ligand1 (L1) tumor proportion score (TPS) of less than 50%.

recurrent non-small cell lung cancer
small cell lung cancer
measurable disease
pembrolizumab
EGFR
  • 0 views
  • 19 Feb, 2024
  • 1 location
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MPP2+ Recurrent or Progressive Glioblastoma

Vaccines made from a gene-modified virus may help the body build an effective immune response to kill tumor cells.

glioblastoma multiforme
mpp2
glioma
serum pregnancy test
leukapheresis
  • 0 views
  • 19 Feb, 2024
  • 1 location